Chargement en cours...
The Emerging Role of Lenalidomide in the Management of Lymphoid Malignancies
Lenalidomide, a novel immunomodulatory drug (IMiD), is a promising therapeutic strategy for patients with relapsed/refractory chronic lymphocytic leukemia (CLL) and B-cell lymphomas. Biologically, the mechanisms responsible for lenalidomide activity are yet to be clearly defined. Based on preclinica...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573391/ https://ncbi.nlm.nih.gov/pubmed/23556075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620710390547 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|